JPS57112331A - Medical composition of ganoderma lucidum component - Google Patents

Medical composition of ganoderma lucidum component

Info

Publication number
JPS57112331A
JPS57112331A JP55187752A JP18775280A JPS57112331A JP S57112331 A JPS57112331 A JP S57112331A JP 55187752 A JP55187752 A JP 55187752A JP 18775280 A JP18775280 A JP 18775280A JP S57112331 A JPS57112331 A JP S57112331A
Authority
JP
Japan
Prior art keywords
thrombosis
ganoderma lucidum
hypertension
reagent
positive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP55187752A
Other languages
Japanese (ja)
Other versions
JPH0148249B2 (en
Inventor
Takeshi Takahashi
Shigeru Yuchi
Michitoku Kubo
Tadahito Tani
Masaya Toyama
Masakatsu Masumori
Norimasa Kirigatani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TOUYOU YAKUSHIYOKU KOGYO KK
TOYO YAKUSHIYOKU KOGYO KK
Original Assignee
TOUYOU YAKUSHIYOKU KOGYO KK
TOYO YAKUSHIYOKU KOGYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TOUYOU YAKUSHIYOKU KOGYO KK, TOYO YAKUSHIYOKU KOGYO KK filed Critical TOUYOU YAKUSHIYOKU KOGYO KK
Priority to JP55187752A priority Critical patent/JPS57112331A/en
Publication of JPS57112331A publication Critical patent/JPS57112331A/en
Publication of JPH0148249B2 publication Critical patent/JPH0148249B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PURPOSE: The titled composition useful for remedying and preventing symptomes complices of thrombosis in the blood, having low toxicity, obtained by subjecting a fruit body of ganoderma lucidum to thermal extraction with water, removing unsoluble components from the extracted solution, followed by concentration and drying.
CONSTITUTION: The titled composition comprising a medicinal component of ganoderma lucidum as an active ingredient. The medical component has the following chemical and physical properties. The maximum absorptions of infrared spectrum (KBr method) are about 3,450, 2,970, 1,700, 1,460, 1,390, and 1,040cm-1; the maximum absorption of ultraviolet spectrum is about 257W258nm; positive in Fehling's reagent, quasipositive in phenylhydrazine reagent, and positive in ninhydrine reaction. This medicinal component is known to have extremely improved effect on hypertension, hyperlipemia and arteriosclerosis, and effective for against a group of diseases, symptomes complices of thrombosis in the blood vessel, spread in a wide range, caused by the formation of thrombosis in the blood vessel, especially thrombosis with hypertension. An oral dose is 10W 300mg/time, and 2W3 times a day.
COPYRIGHT: (C)1982,JPO&Japio
JP55187752A 1980-12-29 1980-12-29 Medical composition of ganoderma lucidum component Granted JPS57112331A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55187752A JPS57112331A (en) 1980-12-29 1980-12-29 Medical composition of ganoderma lucidum component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55187752A JPS57112331A (en) 1980-12-29 1980-12-29 Medical composition of ganoderma lucidum component

Publications (2)

Publication Number Publication Date
JPS57112331A true JPS57112331A (en) 1982-07-13
JPH0148249B2 JPH0148249B2 (en) 1989-10-18

Family

ID=16211574

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55187752A Granted JPS57112331A (en) 1980-12-29 1980-12-29 Medical composition of ganoderma lucidum component

Country Status (1)

Country Link
JP (1) JPS57112331A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60184025A (en) * 1984-03-02 1985-09-19 Toyo Yakushiyoku Kogyo Kk Polysaccharide, separation and use thereof
JP2005162627A (en) * 2003-11-28 2005-06-23 Nippon Menaade Keshohin Kk Medicinal composition of ingredient of ganoderma atrum, ganoderma japonicum, ganoderma sinense or the like
JP2005298391A (en) * 2004-04-09 2005-10-27 Nippon Menaade Keshohin Kk Matrix metalloprotease inhibitor
JP2006028128A (en) * 2004-07-21 2006-02-02 Nippon Menaade Keshohin Kk Thrombosis ameliorating agent
JP2012131754A (en) * 2010-12-24 2012-07-12 Nippon Menaade Keshohin Kk Antithrombotic agent
CN103616339A (en) * 2013-11-07 2014-03-05 培力(南宁)药业有限公司 Detection method for preparation containing ganoderan
JP2015187176A (en) * 2015-07-21 2015-10-29 日本メナード化粧品株式会社 Antithrombotic agents

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60184025A (en) * 1984-03-02 1985-09-19 Toyo Yakushiyoku Kogyo Kk Polysaccharide, separation and use thereof
JPS6338325B2 (en) * 1984-03-02 1988-07-29 Toyo Yakushoku Kogyo Kk
JP2005162627A (en) * 2003-11-28 2005-06-23 Nippon Menaade Keshohin Kk Medicinal composition of ingredient of ganoderma atrum, ganoderma japonicum, ganoderma sinense or the like
JP4536360B2 (en) * 2003-11-28 2010-09-01 日本メナード化粧品株式会社 Antithrombotic
JP2005298391A (en) * 2004-04-09 2005-10-27 Nippon Menaade Keshohin Kk Matrix metalloprotease inhibitor
JP4607484B2 (en) * 2004-04-09 2011-01-05 日本メナード化粧品株式会社 Cancer metastasis inhibitor
JP2006028128A (en) * 2004-07-21 2006-02-02 Nippon Menaade Keshohin Kk Thrombosis ameliorating agent
JP4643936B2 (en) * 2004-07-21 2011-03-02 日本メナード化粧品株式会社 Thrombosis ameliorating agent
JP2012131754A (en) * 2010-12-24 2012-07-12 Nippon Menaade Keshohin Kk Antithrombotic agent
CN103616339A (en) * 2013-11-07 2014-03-05 培力(南宁)药业有限公司 Detection method for preparation containing ganoderan
JP2015187176A (en) * 2015-07-21 2015-10-29 日本メナード化粧品株式会社 Antithrombotic agents

Also Published As

Publication number Publication date
JPH0148249B2 (en) 1989-10-18

Similar Documents

Publication Publication Date Title
JPS53113008A (en) Constant rate releasing preparation
JPS57193412A (en) Prevention of prostatic hyperplasia and therapeutical drug
JPS57112331A (en) Medical composition of ganoderma lucidum component
JPS5228947A (en) Oral remedy for hyperlipemia
JPS57122085A (en) Circulatory disease extirpenter and use
JPS56128721A (en) Antiallergic agent
JPS57126420A (en) Drug for digestive organ
JPS5795914A (en) Antithrombin-like drug
JPS55122724A (en) Antidiabetic agent
JPS5257319A (en) Anticeptic treatment of foods
JPS55122715A (en) Antidiabetic agent
JPS5585526A (en) Remedy for allergic disease
JPS56115720A (en) Prophylactic agent for pigling
JPS53127432A (en) Novel physiologically active substance, anthglutin, and its preparation
JPS5389671A (en) Continuous treating apparatus
SU1042752A1 (en) Method of treating chronic urethritis
IL82317A0 (en) 1,4 dihydropyridine derivatives,processes for their preparation and medicaments containing these compounds
Mongeau et al. Propranolol efficacy in essential hypertension in adolescents.
JPS55118420A (en) Preparation of improved vaccine for hooping cough
JPS5661993A (en) Preparation of immune adjusting substance having antitumor action from mycelium belonging to genus peziza vesiculosa
JPS5742620A (en) Novel antiulcer agent
JPS55111422A (en) Antitumorigenic agent
JPS5731619A (en) Improver for liver function
JPS51125963A (en) Biological treatment method of waste water using migration gas-liquid contact members
Pereverzev et al. The role of APUD-system cells and their mediators in the biological effects of adaptogenes